FDA NDC Directory · JSON-LD · Markdown
NDC 45802-281 · HUMAN PRESCRIPTION DRUG · GEL
| Labeler / Manufacturer | Padagis Israel Pharmaceuticals Ltd |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA205781 |
| Dosage form / route | GEL · TOPICAL |
| Active ingredients | TESTOSTERONE (20.25 mg/1.25g) |
| Marketing started | 20190627 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).